Ardelyx
ARDXNext catalyst
Tenapanor
Hyperphosphatemia
Get an email about ARDX's next catalysts
Track Ardelyx (ARDX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 1 more upcoming event in our data (Phase 3 readout).See the timeline
2 upcoming, 1 past
Tenapanor Phase 2 Est. Readout
Estimated primary completion for Tenapanor trial (NCT06460038) in Synucleinopathy. Topline data typically follows completion by weeks to months.
SourceTenapanor Phase 3 Est. Readout
Primary completion for Tenapanor trial (NCT07382167) in Chronic Idiopathic Constipation (CIC)
SourceHow ARDX's past catalysts played out
Market Overview
Stock performance and key metrics
Sevelamer Carbonate
Hyperphosphatemia
Tenapanor
Hyperphosphatemia
Phosphate Binder Agents
Hyperphosphatemia
AZD1722
Chronic Kidney Disease
AZD1722 (out-patient)
End Stage Renal Disease
RDX5791
Constipation Predominant Irritable Bowel Syndrome
AZD1722 (in-patient)
End Stage Renal Disease
RDX013
Hyperkalemia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Sevelamer Carbonate | Phase 3 | Hyperphosphatemia | - | - |
Tenapanor | Phase 3 | Hyperphosphatemia | - | - |
Phosphate Binder Agents | Phase 3 | Hyperphosphatemia | - | - |
AZD1722 | Phase 3 | Chronic Kidney Disease | - | - |
AZD1722 (out-patient) | Phase 2 | End Stage Renal Disease | - | - |
RDX5791 | Phase 2 | Constipation Predominant Irritable Bowel Syndrome | - | - |
AZD1722 (in-patient) | Phase 2 | End Stage Renal Disease | - | - |
RDX013 | Phase 2 | Hyperkalemia | - | - |
Frequently asked questions
What is in Ardelyx's drug pipeline?→
CatalystAlert tracks 8 drug candidates in Ardelyx's (ARDX) pipeline across Phase 3, Phase 2. Its lead program is Tenapanor (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Ardelyx's next FDA catalyst?→
Ardelyx's (ARDX) next tracked catalyst is a Phase 2 readout expected December 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ARDX biotech catalysts?→
Add ARDX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Ardelyx's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.